DeutschNewstral
Article
Mmarketwatch.com on 2020-06-16 21:01
U.K. approves dexamethasone for some severely ill coronavirus patients
Related news
- MU.K. clinical trial finds steroid reduces death in some severely ill COVID-19 patientsmarketwatch.com
WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patientsherald.co.zw- MNew research underscores benefits of steroids in severely ill COVID-19 patientsmarketwatch.com
Dexamethasone can help save lives of very ill coronavirus patients: British trial findsSouth China Morning Post
Older blood as effective as new for severely ill patientsThe Globe and Mail
U.K. study backs HCMC's bullish use of dexamethasone for COVID-19Star Tribune- HTrial of COVID-19 Blood Plasma Finds No Benefit in Severely Ill Patientshamodia.com
COVID-19 | Govt. approves use of DexamethasoneThe Hindu- Coronavirus | Government approves use of dexamethasoneThe Hindu
- U.K. approves Oxford vaccine for ‘emergency use’The Hindu
- MU.K. trial sparks interest in dexamethasone’s potential as a treatment for severely ill COVID-19 patientsmarketwatch.com
Johnson & Johnson coronavirus vaccine trial paused after participant falls ill; Eli Lilly pauses trial of proposed treatment for severely ill patientscleveland.com
Drug reduces death in one third of seriously ill patientschronicle.co.zw
Death Rates Have Dropped for Seriously Ill Covid PatientsThe New York Times
U.K. approves airstrikes in SyriaArkansas Online- MU.K. approves use of life-saving coronavirus drug dexamethasone in ‘biggest breakthrough yet’marketwatch.com
Severely ill Pussy Riot member to be treated in GermanyThe Findlay Courier